6-hydroxychlorzoxazone,
6-Hydroxychlorzoxazone,
1750-45-4,
5-Chloro-6-hydroxybenzo[d]oxazol-2(3H)-one,
2(3H)-Benzoxazolone, 5-chloro-6-hydroxy-,
NSC 24955,
5-Chloro-6-hydroxy-2-benzoxazolinone,
5-Chloro-6-hydroxybenzoxazone,
6-hydroxy Chlorzoxazone,
2-BENZOXAZOLINONE, 5-CHLORO-6-HYDROXY-,
UNII-M5YLT4Y73F,
BRN 0911674,
M5YLT4Y73F,
5-Chloro-6-hydroxy-2(3H)-benzoxazolone,
2(3H)-Benzoxazolone,5-chloro-6-hydroxy-,
5-chloro-6-hydroxy-1,3-benzoxazol-2(3h)-one,
5-chloro-6-hydroxy-3H-1,3-benzoxazol-2-one,
6-hydroxy chlorzoxazone-d2,
W-206079,
AC1L1ECH,
AC1Q3QW2,
6-Hydroxychlorzoxazone, solid,
SCHEMBL528197,
CHEMBL3182250,
CTK4D5144,
DTXSID50169919,
AGLXDWOTVQZHIQ-UHFFFAOYSA-N,
NSC24955,
5-chloro-6-hydroxy-2-benzoxazolinon,
FCH839820,
MFCD00143502,
NSC-24955,
ZINC95932071,
AKOS006275736,
ACM1750454,
RP03402,
NCGC00165920-01,
6-Hydroxychlorzoxazone, >=98% (HPLC),
AJ-19536,
AK-61019,
AN-49829,
LS-42273,
FT-0669341,
Y7840,
KS-00001830,
chlorzoxazone, 6-hydroxy major metabolit e of c,
750H454,
2(3H)-Benzoxazolone, 5-chloro-6-hydroxy- (9CI),
5-chloro-6-hydroxy-2(3h)-benzoxazolone, 5-chloro-6-hydroxybenzoxazone,
P450 (CYP) metabolite|||Phase I metabolite of chlozoxazone|||CYP2E1 reference metabolite,
6-Hydroxychlorzoxazone solution, 100 mug/mL in methanol, ampule of 1 mL, certified reference material,
C7H4ClNO3,
C7-H4-Cl-N-O3,
CID2734,
AR-1G7806,
6-Hydroxy chlorzoxazone, 98% - 5mg 5mg,
C039289,
1785-05-3,